GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a remarkable development in how we approach type 2 diabetes . These injectable therapies work by imitating the body’s own https://7bookmarks.com/story21593983/glp-1-a-significant-approach-in-blood-sugar-treatment